Home Health News Vaccine developer Moderna may slow COVID trials to add at-risk minorities – The Jerusalem Post

Vaccine developer Moderna may slow COVID trials to add at-risk minorities – The Jerusalem Post

2 min read
0
2

Moderna Inc has been asking sites that are conducting clinical trials of its experimental coronavirus vaccine to focus on enrolling at-risk minorities, even if that slows down the trial speed, the company said on Friday.Shares of Moderna, one of the few companies in the final stages of developing a safe and effective COVID-19 vaccine, closed down about 3.5%.The company said  it has enrolled 21,411 participants in the study so far. It had 17,000 participants as of last week, with 24% from communities of color.The drug developer aims to recruit 30,000 healthy volunteers and said it expected enrollment in the late-stage study, which began in late-July, to be completed in September.A growing body of evidence has shown that long-standing health and social inequities have resulted in increased risk of infection and death from COVID-19 among communities of color. Nearly a fifth of 11,000 people enrolled so far in a 30,000-volunteer U.S. trial testing a COVID-19 vaccine from Pfizer and German partner BioNTech are Black or Latino, groups among the hardest hit by the coronavirus, a top Pfizer executive told Reuters last month.
cnxps.cmd.push(function () cnxps( playerId: ’36af7c51-0caf-4741-9824-2c941fc6c17b’ ).render(‘4c4d856e0e6f4e3d808bbc1715e132f6’); );

Let’s block ads! (Why?)


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Check Also

COVID-19 Statistics | Sept. 18, 2020 – Lost Coast Outpost

Humboldt County’s confirmed COVID-19 case count remains at 482 as no additional cases were…